Multiantagonist and volume therapy for late endotoxin shock.
D000138:Acidosis / Q000209:etiology; D000614:Aminocaproates / Q000627:therapeutic use; D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use; D001639:Bicarbonates / Q000627:therapeutic use; D003533:Cyproheptadine / Q000627:therapeutic use; D004155:Diphenhydramine / Q000627:therapeutic use; D004285:Dogs; D004731:Endotoxins / Q000633:toxicity*; D006493:Heparin / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D012772:Shock, Septic / Q000188:drug therapy*; D014325:Tromethamine / Q000627:therapeutic use
D000614:Aminocaproates; D001639:Bicarbonates; D004731:Endotoxins; D014325:Tromethamine; D010643:Phenoxybenzamine; D003533:Cyproheptadine; D004155:Diphenhydramine; D006493:Heparin; D007611:Aprotinin